OCTAVE DUO - Phase 2 funds: Linked to Phase 1 - Project 1722784

Kearns, Pamela (Principal Investigator)
Rea, Daniel (Co-Investigator)
Richter, Alex (Co-Investigator)
Kirkham, Amanda (Co-Investigator)

Cancer Research UK Clinical Trials Unit

Short title	OCTAVE DUO - Phase 2 funds: Linked to Phase 1 - Project 1722784
Status	Finished
Effective start/end date	13/08/21 → 30/09/23

Funding

Medical Research Council

1 Article

Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trial
OCTAVE-DUO investigators & Parry, H., 8 May 2024, (E-pub ahead of print) In: The Lancet Rheumatology. 6, 6, p. E339-E351 13 p.
Research output: Contribution to journal › Article › peer-review

Open Access
File
19 Downloads (Pure)